Related Experiment Video
Updated: Jul 22, 2025

08:58
Isolation and Cultivation of Mandibular Bone Marrow Mesenchymal Stem Cells in Rats
Published on: August 25, 2020
5.4K
Titanium particles inhibit bone marrow mesenchymal stem cell osteogenic differentiation through the MAPK signaling
Shunyi Tong1, Sanhua Fang1, Kangjie Ying1
1Department of Orthopaedic Surgery, Lanxi People's Hospital, China.
FEBS Open Bio
|July 24, 2023
Summary
Titanium particles from metallic implants inhibit bone cell growth, a key factor in implant loosening. This occurs via the MAPK signaling pathway, impacting orthopedic implant longevity.
Area of Science:
- Biomaterials Science
- Orthopedic Research
- Cell Biology
Background:
- Metallic implants are crucial in orthopedics but face complications like wear debris formation.
- Wear debris from implants, particularly titanium particles, is linked to aseptic loosening and osteolysis around prostheses.
- Understanding wear debris's cellular effects is vital for improving implant survival and patient outcomes.
Purpose of the Study:
- To investigate the impact of titanium particles on the osteogenic differentiation of mesenchymal stem cells.
- To explore the potential mechanisms underlying titanium particle-induced effects on bone cell development.
Main Methods:
- Mesenchymal stem cells were exposed to varying concentrations of titanium particles to simulate wear debris.
- Osteogenic differentiation was assessed.
- The role of the MAPK signaling pathway, specifically ERK1/2 phosphorylation, was examined.
Main Results:
- Titanium particles significantly inhibited osteogenic differentiation of mesenchymal stem cells in a dose-dependent manner.
- Titanium particles were found to significantly affect the phosphorylation of ERK1/2, a key component of the MAPK signaling pathway.
- These findings indicate a direct cellular response to implant wear particles.
Conclusions:
- Titanium particles inhibit mesenchymal stem cell osteogenic differentiation, contributing to aseptic loosening in orthopedic implants.
- The MAPK signaling pathway, involving ERK1/2, plays a critical role in mediating this inhibitory effect.
- Targeting the MAPK pathway may offer strategies to mitigate implant wear complications.
Related Concept Videos
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K

